The structural basis of apoE4's role in Alzheimer's Disease

apoE4 在阿尔茨海默病中作用的结构基础

基本信息

  • 批准号:
    8068746
  • 负责人:
  • 金额:
    $ 24.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-15 至 2013-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Apolipoprotein E (apoE) is a 299 amino acid (~34 kD) protein that plays a central role in lipid transport and metabolism. Unlike apoE3 and apoE2, apoE4 is an established risk factor for Alzheimer's disease (AD). However, the molecular basis of these isoform-specific effects is largely unknown and, most importantly, has not been explored systematically in terms of structure and function. Most attention has been focused on the influence of apoE on A¿ peptide processing in the brain. Specific Aims. Aim 1: Identify the initiation of beta structure in apoE4. Aim 2: Characterize the interaction of apoE isoforms with the A¿ peptide. These aims will illuminate the most important details needed for achieving a mechanistic understanding of how apoE4 participates in AD and neurodegeneration in general. Guided by our (including collaborators) expertise on the functional system, we have the experience and technology to uniquely contribute to this problem by applying the structural biology tools most likely to uncover the basis for the apoE isoform effect in AD. These tools include fluorescence spectroscopy, electron microscopy, surface plasmon resonance, and FTIR spectroscopy, though our primary method will utilize electron paramagnetic (EPR) spectroscopy of site-directed spin labels. Significance. Because of the ability of EPR to report on local structure and spatial relationships from the sample in solution, this work may translate into an effective tool for drug candidate screening. Possibilities include use of spin-labeled side chains to evaluate beta-strand blockers designed to target an identified domain or charged chemical chaperones that stabilize a labile region within apoE. Since apoE3 may also experience destabilized conformations, though at a much lower frequency, such treatments may be helpful in slowing the progression of AD in E3 carriers as well.
描述(由申请人提供):载脂蛋白 E (apoE) 是一种 299 个氨基酸 (~34 kD) 的蛋白质,在脂质转运和代谢中发挥核心作用。与 apoE3 和 apoE2 不同,apoE4 是阿尔茨海默病 (AD) 的既定危险因素。然而,这些亚型特异性效应的分子基础在很大程度上是未知的,最重要的是,尚未在结构和功能方面进行系统的探索。大多数注意力都集中在 apoE 对大脑中 A¿ 肽加工的影响上。 具体目标。 目标 1:确定 apoE4 中 β 结构的起始。 目标 2:表征 apoE 同工型与 A¿ 肽的相互作用。 这些目标将阐明实现 apoE4 如何参与 AD 和神经退行性病变的机制理解所需的最重要细节。在我们(包括合作者)功能系统专业知识的指导下,我们拥有经验和技术,通过应用最有可能揭示 AD 中 apoE 同工型效应基础的结构生物学工具,为解决这个问题做出独特的贡献。这些工具包括荧光光谱、电子显微镜、表面等离子体共振和 FTIR 光谱,尽管我们的主要方法将利用定点自旋标签的电子顺磁 (EPR) 光谱。 意义。由于 EPR 能够报告溶液中样品的局部结构和空间关系,这项工作可能会转化为候选药物筛选的有效工具。可能性包括使用自旋标记侧链来评估β链阻断剂,该β链阻断剂旨在靶向已识别的结构域或稳定apoE内不稳定区域的带电化学伴侣。由于 apoE3 也可能经历不稳定的构象,尽管频率要低得多,因此此类治疗也可能有助于减缓 E3 携带者 AD 的进展。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The influence of spin-labeled fluorene compounds on the assembly and toxicity of the aβ peptide.
  • DOI:
    10.1371/journal.pone.0035443
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Petrlova J;Kálai T;Maezawa I;Altman R;Harishchandra G;Hong HS;Bricarello DA;Parikh AN;Lorigan GA;Jin LW;Hideg K;Voss JC
  • 通讯作者:
    Voss JC
Binding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy.
载脂蛋白 E 的结合抑制溶液中淀粉样β 肽的低聚物生长,如荧光互相关光谱测定。
  • DOI:
    10.1074/jbc.m112.411900
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ly,Sonny;Altman,Robin;Petrlova,Jitka;Lin,Yu;Hilt,Silvia;Huser,Thomas;Laurence,TedA;Voss,JohnC
  • 通讯作者:
    Voss,JohnC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN Carl VOSS其他文献

JOHN Carl VOSS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN Carl VOSS', 18)}}的其他基金

The structural basis of apoE4's role in Alzheimer's Disease
apoE4 在阿尔茨海默病中作用的结构基础
  • 批准号:
    7844863
  • 财政年份:
    2007
  • 资助金额:
    $ 24.1万
  • 项目类别:
The structural basis of apoE4's role in Alzheimer's Disease
apoE4 在阿尔茨海默病中作用的结构基础
  • 批准号:
    7469527
  • 财政年份:
    2007
  • 资助金额:
    $ 24.1万
  • 项目类别:
The structural basis of apoE4's role in Alzheimer's Disease
apoE4 在阿尔茨海默病中作用的结构基础
  • 批准号:
    7616488
  • 财政年份:
    2007
  • 资助金额:
    $ 24.1万
  • 项目类别:
The structural basis of apoE4's role in Alzheimer's Disease
apoE4 在阿尔茨海默病中作用的结构基础
  • 批准号:
    7314754
  • 财政年份:
    2007
  • 资助金额:
    $ 24.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了